The preferred pharmacological treatment is insulin (AACE/ACE, 2010; ADA, 2018; International Diabetes Federation, 2009; Permanente, 2018; SEMDSA, 2017; FIGO, 2015), while metformin and glyburide can be used as effective alternatives (AACE/ACE, 2010; SIGN, 2017; FIGO, 2015) if not contraindicated or unacceptable for the woman (NICE, 2015). Here, INS is linked to diabetes mellitus.